Citation Impact

Citing Papers

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
2015
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
2019 StandoutNobel
Origin and evolution of pathogenic coronaviruses
2018 Standout
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
2018
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections
2019
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
2016
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
2017
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
2020
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
2017 Standout
A guide to immunometabolism for immunologists
2016 Standout
The spectrum of T cell metabolism in health and disease
2017
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Coronaviruses — drug discovery and therapeutic options
2016
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
2020 Standout
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
2016
Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies
2017
Immunogenic cell death in cancer and infectious disease
2016 Standout
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
2019
MERS-CoV spike protein: Targets for vaccines and therapeutics
2016
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
2020 Standout
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
2018
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
2020
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
2020 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months
2013
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
2015
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
2020
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
2015
Neutrophils in cancer: neutral no more
2016 Standout
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
2020 Standout
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
2020 Standout
Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease
2015
mTOR Signaling in T Cell Immunity and Autoimmunity
2014
Middle East respiratory syndrome
2015
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
2016
Inflammation in obesity, diabetes, and related disorders
2022 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
2019
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Identification of Human Single-Domain Antibodies against SARS-CoV-2
2020
Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor
2020 Standout
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
2020
Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1
2015
The application of Chinese medicine to novel drug discovery
2012
A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge
2012
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody
2017
Spermidine in health and disease
2018 StandoutScience
Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections
2017
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
2017
Broad-spectrum coronavirus antiviral drug discovery
2019
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
2020 Standout
MERS, SARS and other coronaviruses as causes of pneumonia
2017
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
2020 Standout
ETCM: an encyclopaedia of traditional Chinese medicine
2018 Standout
MERS-CoV spike protein: a key target for antivirals
2016
Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus
2016
Coronavirus infections and immune responses
2020
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
2015
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
2020 Standout
Coronavirus Infections—More Than Just the Common Cold
2020 Standout
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
2014
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
2020 Standout
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
2020 Standout

Works of Yanping Wang being referenced

Foxp3+ T Cells Inhibit Antitumor Immune Memory Modulated by mTOR Inhibition
2014
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
2017
Qualitative and quantitative analysis in quality control of traditional Chinese medicines
2008
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
2016
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
2015
Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
2014
A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge
2011
Rankless by CCL
2026